Submit Content
Get the latest delivered to your inbox
Privacy Policy

Now Reading

CEOs of Biopharmaceutical Companies CTLT, GSK, INCY, MRK, MRNA, PFE, SNY, TAK, UCB Share Long-Term Business Plans with Institutional Investors

CEOs of Biopharmaceutical Companies CTLT, GSK, INCY, MRK, MRNA, PFE, SNY, TAK, UCB Share Long-Term Business Plans with Institutional Investors

Published 05-20-21

Submitted by CECP

CEO Investor Forum logo and Biopharma Sustainability Roundtable logo


CECP’s CEO Investor Forum and Biopharma Sustainability Roundtable co-hosted Biopharma CEO Investor Forum


Institutional investors and members of the media are invited to hear Long-Term Plan presentations delivered by the following CEOs:

  • Stéphane Bancel, Chief Executive Officer, Moderna (MRNA)
  • Albert Bourla, Chairman and Chief Executive Officer, Pfizer (PFE)
  • John Chiminski, Chair and Chief Executive Officer, Catalent (CTLT)
  • Kenneth C. Frazier, Chairman and Chief Executive Officer, Merck (MRK)
  • Hervé Hoppenot, Chief Executive Officer, Incyte (INCY)
  • Paul Hudson, Chief Executive Officer, Sanofi (SNY)
  • Jean-Christophe Tellier, Chief Executive Officer and Chairman of the Executive Committee, UCB
  • Emma Walmsley, Chief Executive Officer, GSK
  • Christophe Weber, President and Chief Executive Officer, Takeda Pharmaceutical Company Ltd. (TAK)

Additional speakers include:

  • Laura Ahmadi, Research Analyst, Healthcare Sector, Calvert Research and Management
  • Neal Batra, Principal, Deloitte Consulting LLP, and Future of HealthTM Leader
  • Daryl Brewster, CEO, CECP
  • Andrew Edgecliffe Johnson, US News Editor, Financial Times
  • Alex Gorsky, Chairman and Chief Executive Officer, Johnson & Johnson; Co-Chair, CEO Investor Forum (JNJ)
  • Sanjay Gupta, Chief Medical Correspondent, CNN
  • Melanie Ivarsson, Chief Clinical Development Officer, Moderna (MRNA)
  • Bill McNabb, former Chairman, Vanguard; Co-Chair, CEO Investor Forum and Vice Chair, CECP
  • Thomas Schweiller, Founder and Owner, Schweiller Impacts
  • Jeffrey Solomon, CEO, Cowen (COWN)
  • Susanne Stormer, Board Member, SASB
  • Luke Timmerman, Founder and Editor, Timmerman Report
  • Meg Tirrell, Senior Health and Science Reporter, CNBC
  • Tensie Whelan, Clinical Professor and Director, NYU Stern Center for Sustainable Business
  • Additional speakers to be confirmed


June 7, 2021 – 7:45 am – 4:45 pm

June 8, 2021 – 8:30 am – 12:45 pm


Virtual event; click here to register. Attendance is free due to the generosity of the event’s sponsors, Calvert, Cowen, and Deloitte.

# # #


The CECP’s CEO Investor Forum is a global organization preparing corporate leaders for the next generation of stakeholders. The Forum provides support and guidance to CEOs on how to develop and communicate their long-term strategy to institutional investors and other key constituencies. Through a proprietary content framework, advisory services, and events, the Forum empowers CEOs to proactively set the context, own their narrative, and lead toward a sustainable future. CEO Investor Forum is chaired by Bill McNabb, former Chairman, Vanguard and Alex Gorsky, CEO, Johnson & Johnson.  CECP is a CEO-led coalition that believes that a company’s social strategy — how it engages with key stakeholders including employees, communities, investors, and customers —determines company success.  

The CEO Investor Forum, formerly known as the Strategic Investor Initiative, has established itself as a principal research and thought leader in the space of ESG, corporate disclosures, and long-term value creation. Publications including The Return on PurposeReorienting Capital Markets Toward the Long-TermEmerging Practice in Long-Term PlansThe Economic Significance of Long-Term PlansMethod of Production of Long-Term Plans, and ESG and the Earnings Call have been widely cited and republished in leading corporate finance journals and media. See the complete collection of research and resources available on the CEO Investor Forum’s website.  


The Biopharma Sustainability Roundtable is a sector-specific collaboration platform that works with senior biotech and pharma executives to help drive their Sustainability agendas forward. We facilitate a program of webinars and topical forums each spring, a sector-focused survey, and an annual conference in the Fall, all addressing a broad agenda of ESG topics defined in collaboration with our participants. Executives and invited thought leaders come together to explore Sustainability challenges and trends, examine cutting edge industry topics, share best practices, and learn from each other. The Roundtable also facilitates focused initiatives that engage participating biopharma companies and key stake holders, such as the Biopharma Investor ESG Communications Initiative now working with CECP. Learn more at 




The Committee Encouraging Corporate Philanthropy (CECP) is the only international forum of business leaders focused on increasing the level and quality of corporate philanthropy. Membership includes more than 180 global CEOs and chairpersons of companies that collectively account for more than 40% of reported corporate giving in the United States. Membership is by invitation and is renewed annually.

CECP provides member companies with peer-to-peer executive convenings, premier networking events for corporate giving industry professionals, cutting-edge research publications, a proprietary, on-demand benchmarking system of corporate philanthropy data, and exclusive media opportunities.

Founded in 1999 by actor and philanthropist Paul Newman, together with John Whitehead, Peter Malkin, and other business leaders, CECP continues to inspire and challenge leaders in the private sector to find innovative ways to fulfill unmet social needs and to lead the way towards better alignment of business and social strategies.

Join CECP on Facebook, Twitter, Flickr and YouTube.

More from CECP

Join today and get the latest delivered to your inbox